$34.99
-0.41 (-1.16%)
Performance
1D
—
1W
—
1M
—
3M
+0.43%
6M
+7.17%
1Y
+16.13%
YTD
+23.81%
Open$35.77
Previous Close$35.40
Day High$35.93
Day Low$34.87
52W High$36.60
52W Low$25.17
Volume—
Avg Volume2.05M
Market Cap5.95B
P/E Ratio24.62
EPS$1.43
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$31.02
Above
SMA 200
$29.87
Above
RSI (14)
32.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
+261.2% upside
Current
$34.99
$34.99
Target
$126.40
$126.40
$90.34
$126.40 avg
$146.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.49B | 1.35B | 1.89B |
| Net Income | 243.54M | 199.44M | 267.01M |
| Profit Margin | 16.4% | 15.6% | 14.1% |
| EBITDA | 265.07M | 229.13M | 438.15M |
| Free Cash Flow | — | — | 233.31M |
| Rev Growth | +9.9% | +9.9% | +6.3% |
| Debt/Equity | — | — | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |